Skip to main content

Table 3 Participant (patient) characteristics

From: The experience of foot problems and decisions to access foot care in patients with rheumatoid arthritis: a qualitative study

ID

Gender

Age (years)

Disease duration (years)

Current medication

HAQ

Patient global

Foot global

Accessed foot care

1

Male

61

3

Biologics, DMARDs, GC

2.875

6

6

Yes

2

Female

62

2

DMARDs, GC

0.375

2

3

No

3

Male

39

2

DMARDs, GC, NSAIDs

0

1

1

No

4

Male

55

27

Biologics, DMARDs, NSAIDs

2.75

8

9

Yes

5

Female

61

23

DMARDS, GC, NSAIDs

2.75

7

7

Yes

6

Male

54

2

Biologics, DMARDS, GC, NSAIDs

2

8

9

No

7

Female

71

11

Biologics

0.375

7

1

No

8

Male

72

20

DMARDs, NSAIDs

1.87

9

5

Yes

9

Female

46

24

Biologics, DMARDs, NSAIDs

2.375

6

8

Yes

10

Female

29

5

GC

0

0

0

No

11

Female

55

7

DMARDs, NSAIDs

1.87

5

7

Yes

12

Female

69

18

DMARDs

1.75

7

8

Yes

Mean

 

56.2

12.0

 

1.56

5.5

5.3

 

Range

 

(29–72)

(2–27)

 

(0–2.875)

(0–9)

(0–9)

 
  1. Key:
  2. ID Patient identifier
  3. DMARDs Disease-modifying anti-rheumatic drugs
  4. GC Glucocorticoids
  5. NSAIDs Non-steroidal anti-inflammatory drugs
  6. HAQ Health Assessment Questionnaire score 0–3 (3 is most disabled)
  7. Patient Global = Numerical rating scale 0 (very well) -10 (10 very badly)
  8. Foot Global = Numerical rating scale 0 (no problem) -10 (10 severe problem)